Francesca Sidoti

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus

Graft microvascular disease in solid organ transplantation

The “ABC” of Virus-Specific T Cell Immunity in Solid Organ Transplantation

Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation

Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation

The complex microbiota of raw milk

Nation-wide measure of variability in HCMV, EBV and BKV DNA quantification among centers involved in monitoring transplanted patients

Crohn’s disease and the mycobacterioses: A quarter century later. Causation or simple association?

CRISPR–Cas12-based detection of SARS-CoV-2

Herpes Viruses in Transplant Recipients: HSV, VZV, Human Herpes Viruses, and EBV

A multiplexed RT-LAMP assay for detection of group M HIV-1 in plasma or whole blood

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

Late-Onset Cytomegalovirus (CMV) in Lung Transplant Recipients: Can CMV Serostatus Guide the Duration of Prophylaxis?

Current Understanding of the Acute Exacerbation of Chronic Rhinosinusitis

State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician

Cytotoxic T-cell and NK-cell Lymphomas

Impact of Respiratory Virus Infections in Exacerbation of Acute and Chronic Rhinosinusitis

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

Bacterial Biofilm and its Role in the Pathogenesis of Disease

An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity

Fewer cytomegalovirus complications after kidney transplantation by de novo use of mTOR inhibitors in comparison to mycophenolic acid

Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients

Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis

Evaluation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients

Everolimus-based immunosuppressive regimens in lung transplant recipients: Impact on CMV infection

Alternative Molecular Tests for Virological Diagnosis

Evaluation of CMV-specific cellular immune response by EliSPOT assay in kidney transplant patients

Evaluation of Epstein-Barr Virus–Specific Immunologic Response in Solid Organ Transplant Recipients With an Enzyme-Linked ImmunoSpot Assay

Epstein-Barr Virus in Cutaneous T-Cell Lymphomas: Evaluation of the Viral Presence and Significance in Skin and Peripheral Blood

Detection of Herpesviruses 1-6 and Community-Acquired Respiratory Viruses in Patients with Chronic Rhinosinusitis with Nasal Polyposis

Comparison of two nucleic acid extraction and testing systems for HCMV-DNA detection and quantitation on whole blood specimens from transplant patients

Human herpes virus 8 infection in kidney transplant patients from an area of northwestern Italy (Piemonte region)

Non‐organ‐specific and anti‐endothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients

Validation and standardization of IS900 and F57 real-time quantitative PCR assays for the specific detection and quantification ofMycobacterium aviumsubsp.paratuberculosis